About: http://data.cimple.eu/news-article/9c8a79a85dace19586f7e78ca565e2449e7e34e8d4c3fc678957c220

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/9c8a79a85dace19586f7e78ca565e2449e7e34e8d4c3fc678957c220 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The EU's medicines regulator said Friday it is investigating reports of possible "acute" kidney damage in patients taking the coronavirus drug remdesivir, made by US pharma giant Gilead. The European Medicines Agency recommended the use of the anti-viral drug, sold under the brand name Veklury, in June after studies showed it could reduce the length of hospital stays for Covid-19 sufferers. "EMA's safety committee has started a review... to assess reports of acute kidney injury in some patients with COVID-19 taking Veklury (remdesivir)," it said in a statement. The regulator said it had "not been determined whether there is a causal relationship" between remdesivir and kidney problems, but that the issue "warrants further investigation." Covid-19 itself could also cause kidney injuries, the regulator noted. Recommendations for using the drug had not changed for now, the EMA said, adding that approval had been fast-tracked for use with coronavirus patients on the basis that further tests would be carried out. If a link to kidney problems was proved, any change would probably be limited to making leaflets with the drug alerting users to possible side-effects, it said. The World Health Organization said remdesivir was "still being tested in trials". "We are in very close contact with the European Medicines Agency and we follow any investigations that they are doing," said Emer Cook, director of pre-qualification and regulation at the WHO. "As far as I understand this investigation is at an early stage of development, but we will be in touch and make sure that we follow up and liaise in terms of the trials that are ongoing." dk-apo/mbx
schema:headline	EU regulator probes possible kidney damage from coronavirus drug
schema:mentions	Acute kidney injury I Understand (1941 song) European Medicines Agency Antiviral drug Remdesivir World Health Organization European Union Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Nephrotoxicity Emer Gilead Sciences
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-10-02 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	81 (xsd:integer)
http://data.cimple...tology#hasEmotion	fear

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software